Cargando…

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4(+) T Cells From HIV-1 Patients

We described a novel HIV autologous isolation method based in coculturing macrophages and CD4(+)T-cell-enriched fractions from peripheral blood collected from antiretroviral-treated (ART) HIV patients. This method allows the isolation of high viral titers of autologous viruses, over 10(10)HIV RNA co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xufré, Cristina, González, Tanía, Leal, Lorna, Trubey, Charles M., Lifson, Jeffrey D., Gatell, José María, Alcamí, José, Climent, Núria, García, Felipe, Sánchez-Palomino, Sonsoles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364968/ https://www.ncbi.nlm.nih.gov/pubmed/35967461 http://dx.doi.org/10.3389/fviro.2022.869431

Ejemplares similares

Impact of Transcriptome and Gut Microbiome on the Response of HIV-1 Infected Individuals to a Dendritic Cell-Based HIV Therapeutic Vaccine
por: Pastor-Ibáñez, Roque, et al.
Publicado: (2021)

Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging
por: Rodríguez-Agustín, Andrea, et al.
Publicado: (2023)

Generation and Characterization of a Defective HIV-1 Virus as an Immunogen for a Therapeutic Vaccine
por: Álvarez-Fernández, Carmen, et al.
Publicado: (2012)

Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
por: Leal, Lorna, et al.
Publicado: (2021)

Use of RT-Defective HIV Virions: New Tool to Evaluate Specific Response in Chronic Asymptomatic HIV-Infected Individuals
por: Guardo, Alberto Crespo, et al.
Publicado: (2013)

ω-3 supplementation in HIV-1-infected individuals with unsuppressed viral load: cause for caution?
por: Tort, Olivia, et al.
Publicado: (2016)

Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8(+) T Cell Responses in HIV-1-Infected Individuals
por: Climent, Núria, et al.
Publicado: (2011)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Increased α-Defensins 1-3 Production by Dendritic Cells in HIV-Infected Individuals Is Associated with Slower Disease Progression
por: Rodríguez-García, Marta, et al.
Publicado: (2010)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

HIV‐1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion
por: Morén, Constanza, et al.
Publicado: (2016)

Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected Individuals
por: Pastor-Ibáñez, Roque, et al.
Publicado: (2021)

Distinct Requirements for HIV-1 Accessory Proteins during Cell Coculture and Cell-Free Infection
por: Zotova, Anastasia, et al.
Publicado: (2019)

Loading dendritic cells from HIV-1 infected patients with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses
por: Climent, N, et al.
Publicado: (2012)

HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
por: Blanco, Jose-Luis, et al.
Publicado: (2011)

Association of Transcriptomic Signatures of Inflammatory Response with Viral Control after Dendritic Cell-Based Therapeutic Vaccination in HIV-1 Infected Individuals
por: Fehér, Csaba, et al.
Publicado: (2021)

Immune Activation Promotes Evolutionary Conservation of T-Cell Epitopes in HIV-1
por: Sanjuán, Rafael, et al.
Publicado: (2013)

Adenosine Deaminase Enhances the Immunogenicity of Human Dendritic Cells from Healthy and HIV-Infected Individuals
por: Casanova, Víctor, et al.
Publicado: (2012)

3-Phenylcoumarins as Inhibitors of HIV-1 Replication
por: Olmedo, Dionisio, et al.
Publicado: (2012)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

High rates of long‐term progression in HIV‐1‐positive elite controllers
por: Borrell, Maria, et al.
Publicado: (2021)

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: C. Guardo, Alberto, et al.
Publicado: (2017)

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
por: Guardo, Alberto C., et al.
Publicado: (2018)

Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals
por: Kawana-Tachikawa, Ai, et al.
Publicado: (2014)

Preclinical development of BCG.HIVA(2auxo.int), harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity
por: Mahant, Aakash, et al.
Publicado: (2017)

P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy
por: Moraes, SL, et al.
Publicado: (2009)

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins
por: Jan, Muzafar, et al.
Publicado: (2018)

RNA remarkably promotes HIV-1 protease fast turnover for NCp15 processing in mild acidic conditions leading to condensation of HIV-1 nucleocapsid
por: Lyonnais, Sebastien, et al.
Publicado: (2013)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
por: Leal, Lorna, et al.
Publicado: (2020)

Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
por: González, Nuria, et al.
Publicado: (2018)

Stimulation of carbon nanomaterials on syntrophic oxidation of butyrate in sediment enrichments and a defined coculture
por: Zhang, Wei, et al.
Publicado: (2018)

Cholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
por: Tort, Olivia, et al.
Publicado: (2018)

P10-13. Increased production of alpha-defensins 1–3 by dendritic cells in HIV-infected individuals is associated with a slower disease progression rate
por: Rodriguez-Garcia, M, et al.
Publicado: (2009)

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity
por: Bedoya, Luis M., et al.
Publicado: (2016)

HIV Impacts CD34(+) Progenitors Involved in T-Cell Differentiation During Coculture With Mouse Stromal OP9-DL1 Cells
por: Tsukamoto, Tetsuo
Publicado: (2019)

Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression
por: Vitallé, Joana, et al.
Publicado: (2017)

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes
por: De La Torre-Tarazona, Erick, et al.
Publicado: (2022)

HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission
por: Baan, Elly, et al.
Publicado: (2013)

The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
por: Hens, Jef, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8kemfeqn08lg8eripbdrnu92s